Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Quek

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Oncology|April 13, 2015
Tumour vascular-disrupting agents in soft-tissue sarcomaRichard Quek
Hematology/Oncology Clinics of North America|March 3, 2009
Gastrointestinal stromal tumor: a clinical overviewRichard Quek, Suzanne George
Chinese Clinical Oncology|September 4, 2018
Soft tissue sarcoma in AsiaEileen Poon, Richard Quek
Biologics : Targets & Therapy|February 18, 2010
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinibRichard Quek, Suzanne George
Acta Oncologica (Stockholm, Sweden)|February 9, 2006
Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomideRichard Quek, Soon Thye Lim, Simon Ong
Lancet (London, England)|November 23, 2006
Pneumoperitoneum following percutaneous lung biopsyRichard Quek, Soon Thye Lim, Eng Huat Tan
Leukemia & Lymphoma|January 19, 2008
Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histologySoon Thye Lim, Siew Wan Hee, Richard Quek, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 29, 2014
Symptom burden and medication use in adult sarcoma patientsAlexandre Chan, Eunice Lim, Terence Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Relevance of the International Prognostic Index in the rituximab eraKevin Tay, David Tai, Miriam Tao, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Soft-tissue sarcomas in the Asia-Pacific region: a systematic reviewRoger Ngan, Edward Wang, David Porter, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Oncology|April 13, 2015
Tumour vascular-disrupting agents in soft-tissue sarcomaRichard Quek
Hematology/Oncology Clinics of North America|March 3, 2009
Gastrointestinal stromal tumor: a clinical overviewRichard Quek, Suzanne George
Chinese Clinical Oncology|September 4, 2018
Soft tissue sarcoma in AsiaEileen Poon, Richard Quek
Biologics : Targets & Therapy|February 18, 2010
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinibRichard Quek, Suzanne George
Acta Oncologica (Stockholm, Sweden)|February 9, 2006
Hepatocellular carcinoma--Pathological complete response to oral capecitabine, megestrol and thalidomideRichard Quek, Soon Thye Lim, Simon Ong
Lancet (London, England)|November 23, 2006
Pneumoperitoneum following percutaneous lung biopsyRichard Quek, Soon Thye Lim, Eng Huat Tan
Leukemia & Lymphoma|January 19, 2008
Performance status is the single most important prognostic factor in lymphoma patients aged greater than 75 overriding other prognostic factors such as histologySoon Thye Lim, Siew Wan Hee, Richard Quek, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 29, 2014
Symptom burden and medication use in adult sarcoma patientsAlexandre Chan, Eunice Lim, Terence Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Relevance of the International Prognostic Index in the rituximab eraKevin Tay, David Tai, Miriam Tao, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|January 1, 2014
Soft-tissue sarcomas in the Asia-Pacific region: a systematic reviewRoger Ngan, Edward Wang, David Porter, et al.
Pageof 8